Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Author： Hu William Chen-Plotkin Alice Arnold Steven Grossman Murray Clark Christopher Shaw Leslie Pickering Eve Kuhn Max Chen Yu McCluskey Leo Elman Lauren Karlawish Jason Hurtig Howard Siderowf Andrew Lee Virginia Soares Holly Trojanowski John

Publisher： Springer Publishing Company

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.119, Iss.6, 2010-06, pp. : 669-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Biomarkers of Alzheimer′s Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment

By Monge-Argilés J. Muñoz-Ruiz C. Pampliega-Pérez A. Gómez-López M. Sánchez-Payá J. Rodríguez Borja E. Ruiz-Vegara M. Montoya-Gutiérrez F. Leiva-Santana C.

Neurochemical Research, Vol. 36, Iss. 6, 2011-06 ,pp. : 986-993

Springer Publishing Company

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F. Forlenza O. V. Talib L. L. Barbosa N. R. Bottino C. M. C.

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Comparing regional brain atrophy in mild cognitive impairment and Alzheimer’s disease

By Weiler Marina Cendes Fernando Balthazar Marcio LF

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 417-426

Future Medicine

Access to resources Recommend Favorite

Biomarkers of alzheimer's disease and mild cognitive impairment: are we there yet?

By Turner R.S.

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 7-10

Elsevier

Access to resources Recommend Favorite